This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Yuval Zohar, MD; Rima Sadov, MD; Yytschak Shvili, MD; Yoav Talmi, MD; Nelo Laurian, MD

Arch Otolaryngol Head Neck Surg. 1987;113(7):754-757.

Abstract
• The most common manifestation of hereditary hemorrhagic telangiectasia (HH) is recurrent epistaxis. Numerous treatments have been used over the years, none proving entirely satisfactory. We have applied a new surgical treatment in seven selected cases of HHT with severe, life-threatening epistaxis. It consists of a near-total excision of the diseased nasal mucosa and its replacement by different skin flaps or a myocutaneous flap. This procedure has been performed since 1981. We stress the reliability and versatility of using the forehead myocutaneous island flap. Our original technique is described, follow-up of the patients is reported, and the criteria for selection of treatment are discussed.

(Arch Otolaryngol Head Neck Surg 1987;113:754-757)

Author Affiliations
From the Department of Otolaryngology, Hasharon Hospital, Petah-Tiqva, Israel.

Footnotes
Accepted for publication Dec 15, 1986.

Reprint requests to Department of Otolaryngology, Hasharon Hospital, 49372 Petah-Tiqva, Israel (Dr Zohar).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Management of Epistaxis
MORGENSTEIN
Arch Otolaryngol Head Neck Surg 1987;113:1338-1338.
ABSTRACT